Hook
Get superfood smoothies to help on your GLP-1 journey — delivered right to your door.
Angle
GLP-1 companion positioning for a food-subscription brand: nutrition support, not drug claims.
Offer
50% off first box — revivesuperfoods.com
Creative structure
- 1.Trend-rider hook — 'Get superfood smoothies to help on your GLP-1 journey.' Names the drug wave without touching the drug's function.
- 2.Companion positioning — nutrition support alongside a medication decision the customer already made with their doctor; never an alternative, never a booster.
- 3.Convenience beat — 'delivered right to your door,' the subscription-food logistics promise.
- 4.Hard offer close — 50% off the first box.
Compliance read
A masterclass in riding a drug trend legally. The word 'journey' does all the work: it frames the product as support for a protocol the customer is already on, so the ad makes no claim about weight loss, appetite, or GLP-1 activity at all. Contrast this with the 'nature's Ozempic' supplement ads that FTC and FDA have both moved against — those claim the drug's mechanism or outcome; this claims only adjacency. Being a food product buys extra latitude, but the framing is copyable by supplement brands serving the same population (protein, fiber, micronutrient needs of reduced-appetite GLP-1 users). The single line this positioning cannot cross: implying the smoothies boost, replicate, or replace the medication's effect. 'On your journey' is compliant; 'nature's answer to Ozempic' is a warning letter.
Scale & longevity
213 days on an operator budget with 3 variants — and the tailwind is structural: every new GLP-1 prescription mints a new customer with a nutrition problem this product answers. Companion positioning has years of runway and no claim decay, because the ad never made a claim that could expire.
Steal this
- Use companion framing — 'on your GLP-1 journey' — to serve drug-wave customers: support the protocol they're already on, and never echo the drug's own outcome claims.
- Sell the side-problem, not the headline problem: GLP-1 users need protein, fiber, and micronutrients on suppressed appetites — position for that gap instead of promising weight loss.
- Front-load the discount (50% off first box) when the product is a subscription — aggressive first-order economics are defensible when LTV is recurring, and the offer carries zero compliance weight.